MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-01-0021552
Kureasia Pharma Private Limited
Kureasia Pharma Private Limited - chemicals in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹37.78 Cr
▲ 154% YoY
Net profit · FY 2025
₹59.25 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹4.76 Cr
EBITDA margin 12.6%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹10.4 Cr
Satisfied ₹7.91 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
49
Provident fund records
About Kureasia Pharma Private Limited
Data last updated:
Kureasia Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 29 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2015PTC288996. Its GSTIN is 05AAGCK0491E1ZT (Uttarakhand).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors Shaheer Zaman Ariz and Yashpal Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 255 Right Portion, 3rd Floor Blk – B Ph 1, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹37.78 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹59.25 Lakh (net margin 1.6%) and EBITDA of ₹4.76 Cr (EBITDA margin 12.6%). Revenue has grown at a compounded annual rate (CAGR) of 95% over three years and 53% over five years.
The company has about 49 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10.4 Cr and satisfied charges of ₹7.91 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Kureasia Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0021552). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U85100DL2015PTC288996
Registration Number 288996
Incorporation Date 29 December 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0021552
Recognitions & Rankings of Kureasia Pharma
Contact details
Kureasia Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 255 Right Portion, 3rd Floor Blk – B Ph 1, New Delhi, Delhi, India – 110028
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Kureasia Pharma Private Limited, buy the company report.
Comprehensive company report
Kureasia Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Kureasia Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Kureasia Pharma Private Limited, buy the company report.
Financials of Kureasia Pharma Private Limited
FY 2025 filings availableKureasia Pharma Private Limited reported revenue of ₹37.78 Cr (up 154% YoY) for FY 2025.
Revenue · FY 2025
₹37.78 Cr ▲ 154%
Net profit · FY 2025
₹59.25 Lakh margin 1.6%
EBITDA · FY 2025
₹4.76 Cr margin 12.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 154%
3 years · compounded
▲ 95%
5 years · compounded
▲ 53%
EBITDA CAGR growth
1 year
▲ 86%
3 years · compounded
▲ 189%
5 years · compounded
▲ 92%
Revenue has grown at a compounded annual rate (CAGR) of 53% over five years, including 154% growth in the latest year. EBITDA rose 86% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹37.78 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.76 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.6% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kureasia Pharma Private Limited, buy the company report.
Board of directors of Kureasia Pharma Private Limited
Kureasia Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaheer Zaman Ariz Also directs: Medifirm Pharmacy LLP, Rockmed Pharma Private Limited | Director | 29 Dec 2015 | 10 Years 10 Months | Current |
| Yashpal Arora Also directs: Medifirm Pharmacy LLP, Rockmed Pharma Private Limited | Director | 29 Dec 2015 | 10 Years 10 Months | Current |
Peer comparison
Kureasia Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kureasia Pharma Private Limitedthis company | ₹37.78 Cr (FY 2025) | ₹59.25 Lakh | 1.6% | 154.0% | 49 | New Delhi, Delhi, India |
| Revive Formulations India Private Limited | ₹14.93 Cr (FY 2024) | 5.0% | Vanur, Tamil Nadu, India | |||
| Theo Pharma Pvt Ltd | ₹14.91 Cr (FY 2025) | 26.0% | Ahmedabad, Gujarat, India | |||
| Raymed Pharmaceuticals Limited | ₹14.9 Cr (FY 2025) | -2.0% | Chandigarh, India | |||
| B D Pharmaceutical Works Private Limited | ₹14.82 Cr (FY 2024) | 11.0% | Kolkata, West Bengal, India | |||
| Vav Lipids Private Limited | ₹14.81 Cr (FY 2024) | -17.0% | Mumbai, Maharashtra, India | |||
| Sridhara Laboratories Private Limited | ₹14.8 Cr (FY 2025) | 37.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Kureasia Pharma Private Limited, buy the company report.
Auditor
Kureasia Pharma Private Limited is audited by J R KUMAR & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| J R KUMAR & CO. | FY 2024 | 014880N |
Shareholding
The shareholding of Kureasia Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Kureasia Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.4 Cr
Satisfied charges
₹7.91 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Apr 2025 | 101103774 | Others | ₹5 Cr | Open | |
| 28 Apr 2025 | 101103457 | Others | ₹5.4 Cr | Open | |
| 29 Apr 2023 | 100710211 | Others | ₹7.91 Cr | Satisfied |
To see the full charge records of Kureasia Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Kureasia Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
| Bombay High Court | Court case (LPETN) | Filed against the company by Sun Pharmaceutical Industries Limited | Pending |
To see the full case history of Kureasia Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kureasia Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Kureasia Pharma Private Limited has a workforce of 49 employees on its EPFO records as of Feb 24, 2025, across 1 active EPFO establishment.
Employee count
49
Active EPFO establishments
1
Employee growth
63.33%
GST
Kureasia Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAGCK0491E1ZT | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kureasia Pharma Private Limited, buy the company report.
Recent activity
Kureasia Pharma Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Shaheer Zaman Ariz was appointed as Director on 29 Dec 2015.
AGM
Kureasia Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 29 Apr 2023 via Charge ID 100710211 with Others was fully satisfied on 22 May 2025.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101103774 was registered on 30 Apr 2025.
Charges
A charge with Others amounted to Rs. 5.40 Cr with Charge ID 101103457 was registered on 28 Apr 2025.
Filing
Kureasia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Others of Rs. 7.91 Cr registered on 29 Apr 2023 with Charge ID 100710211 was modified on 30 Jun 2024.
Charges
A charge with Others amounted to Rs. 7.91 Cr with Charge ID 100710211 was registered on 29 Apr 2023.
Appointed
Shaheer Zaman Ariz was appointed as Director.
Appointed
Yashpal Arora was appointed as Director.
Incorporation
29 Dec 2015
Kureasia Pharma Private Limited was registered on 29 Dec 2015 with Roc Delhi I & aged 10 years 10 months as per MCA records.
Frequently asked questions
Kureasia Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 29 December 2015 (11+ years old) and is registered under CIN U85100DL2015PTC288996.
Kureasia Pharma has 2 current directors:
- Shaheer Zaman Ariz - Director
- Yashpal Arora - Director
The latest financial statements of Kureasia Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Kureasia Pharma is 05AAGCK0491E1ZT, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Kureasia Pharma is U85100DL2015PTC288996. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kureasia Pharma has 2 court cases on record: 2 filed against it. 2 are pending.
Kureasia Pharma was incorporated on 29 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Kureasia Pharma by revenue are Revive Formulations India Private Limited, Theo Pharma Pvt Ltd, Raymed Pharmaceuticals Limited, B D Pharmaceutical Works Private Limited, Vav Lipids Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shaheer Zaman Ariz was appointed as Director on 29 Dec 2015. Yashpal Arora was appointed as Director on 29 Dec 2015.
Yes, Kureasia Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0021552).
The registered office of Kureasia Pharma is at Plot No 255 Right Portion, 3rd Floor Blk – B Ph 1, New Delhi, Delhi, India – 110028.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages